Drug Designed to Fight MS Could Target Viral Infections
Reuters is reporting today that a new drug, FTY720, also called fingolimod, that Novartis AG is testing in individuals with multiple sclerosis could also tackle some viral infections, including perhaps including meningitis and perhaps even the AIDS virus. For the complete article, CLICK HERE.
Source: Reuters
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Recent Videos
Related Content
